Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ... New England Journal of Medicine 385 (24), e83, 2021 | 887 | 2021 |
Effects of previous infection and vaccination on symptomatic omicron infections HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... New England Journal of Medicine 387 (1), 21-34, 2022 | 482 | 2022 |
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ... Nature medicine 27 (12), 2136-2143, 2021 | 463 | 2021 |
Three Indonesian clusters of H5N1 virus infection in 2005 IN Kandun, H Wibisono, ER Sedyaningsih, Yusharmen, ... New England Journal of Medicine 355 (21), 2186-2194, 2006 | 447 | 2006 |
Protection against the Omicron variant from previous SARS-CoV-2 infection HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ... New England Journal of Medicine 386 (13), 1288-1290, 2022 | 417 | 2022 |
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ... Nature medicine 27 (9), 1614-1621, 2021 | 406 | 2021 |
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ... New England Journal of Medicine 386 (19), 1804-1816, 2022 | 378 | 2022 |
Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense reexposure setting LJ Abu-Raddad, H Chemaitelly, JA Malek, AA Ahmed, YA Mohamoud, ... Clinical Infectious Diseases 73 (7), e1830-e1840, 2021 | 239 | 2021 |
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ... Nature communications 13 (1), 3082, 2022 | 227 | 2022 |
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy LJ Abu-Raddad, H Chemaitelly, P Coyle, JA Malek, AA Ahmed, ... EClinicalMedicine 35, 2021 | 187 | 2021 |
Association of prior SARS-CoV-2 infection with risk of breakthrough infection following mRNA vaccination in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, HM Yassine, FM Benslimane, ... Jama 326 (19), 1930-1939, 2021 | 158 | 2021 |
COVID-19 infection among healthcare workers in a national healthcare system: The Qatar experience J Alajmi, AM Jeremijenko, JC Abraham, M Alishaq, EG Concepcion, ... International Journal of Infectious Diseases 100, 386-389, 2020 | 153 | 2020 |
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic LJ Abu-Raddad, H Chemaitelly, HH Ayoub, Z Al Kanaani, A Al Khal, ... Scientific reports 11 (1), 6233, 2021 | 144 | 2021 |
COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar J Saththasivam, SS El-Malah, TA Gomez, KA Jabbar, R Remanan, ... Science of the Total Environment 774, 145608, 2021 | 133 | 2021 |
Protective effect of previous SARS-CoV-2 infection against Omicron BA. 4 and BA. 5 subvariants HN Altarawneh, H Chemaitelly, HH Ayoub, MR Hasan, P Coyle, ... New England Journal of Medicine 387 (17), 1620-1622, 2022 | 117 | 2022 |
Duration of immune protection of SARS-CoV-2 natural infection against reinfection H Chemaitelly, N Nagelkerke, HH Ayoub, P Coyle, P Tang, HM Yassine, ... Journal of Travel Medicine 29 (8), taac109, 2022 | 95 | 2022 |
Waning mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar LJ Abu-Raddad, H Chemaitelly, R Bertollini New England Journal of Medicine 386 (11), 1091-1093, 2022 | 93 | 2022 |
Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 AS Omrani, SA Pathan, SA Thomas, TRE Harris, PV Coyle, CE Thomas, ... EClinicalMedicine 29, 2020 | 93 | 2020 |
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses LJ Abu-Raddad, H Chemaitelly, HM Yassine, FM Benslimane, ... Journal of travel medicine 28 (7), taab083, 2021 | 88 | 2021 |
Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19 HH Ayoub, H Chemaitelly, S Seedat, M Makhoul, Z Al Kanaani, A Al Khal, ... Journal of Global Health 11, 2021 | 79 | 2021 |